Back
Day Range
$3.23
$3.37
52-Week Range
$1.11
$5.47
Volume
3,029,446
50D / 200D Avg
$4.17
/
$3.40
Prev Close
$3.28
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.7 | 0.4 |
| P/B | 25.3 | 2.9 |
| ROE % | -160.8 | 3.8 |
| Net Margin % | -3216.2 | 3.9 |
| Rev Growth 5Y % | -40.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Revenue declined -40.82% annually over 5 years
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -76.76M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.87%
Capital intensive — 218.70% of revenue goes to capex
Growth
Revenue Growth (5Y)
-40.82%
Revenue (1Y)-36.95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-160.80%
ROIC-230.08%
Net Margin-3216.18%
Op. Margin-3440.23%
Safety
Debt / Equity
0.14
Current Ratio4.76
Interest Coverage-22504.83
Valuation
P/E Ratio
-7.71
P/B Ratio25.27
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -36.95% | Revenue Growth (3Y) | -61.81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -40.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.93M | Net Income (TTM) | -126.24M |
| ROE | -160.80% | ROA | -86.90% |
| Gross Margin | -8.71% | Operating Margin | -3440.23% |
| Net Margin | -3216.18% | Free Cash Flow (TTM) | -76.76M |
| ROIC | -230.08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 4.76 |
| Interest Coverage | -22504.83 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -7.71 | P/B Ratio | 25.27 |
| P/S Ratio | 248.00 | PEG Ratio | -0.12 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 973.39M | Enterprise Value | 949.37M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 3.93M | 6.23M | 26.91M | 14.27M | 31.99M |
| Net Income | -126.24M | -95.90M | 28.32M | -92.17M | -170.52M |
| EPS (Diluted) | -0.47 | -0.39 | -0.33 | -0.47 | -1.02 |
| Gross Profit | -342,000.0 | 106,000.0 | 20.57M | -39.41M | -12.81M |
| Operating Income | -135.03M | -99.76M | -75.73M | -91.95M | -86.32M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 145.27M | 151.04M | 215.98M | 359.86M | 314.59M |
| Total Liabilities | 106.75M | 32.55M | 89.72M | 252.51M | 247.41M |
| Shareholders' Equity | 38.51M | 118.50M | 126.26M | 107.35M | 67.17M |
| Total Debt | 5.50M | 7.10M | 51.42M | 190.07M | 182.28M |
| Cash & Equivalents | 29.52M | 7.58M | 4.86M | 36.42M | 51.79M |
| Current Assets | 102.41M | 68.76M | 118.16M | 156.63M | 148.95M |
| Current Liabilities | 21.52M | 22.99M | 78.65M | 34.65M | 42.13M |